PF-Atlas › Clinical Trials › NCT00749866

Long Term Nebulised Gentamicin in Patients With Bronchiectasis

Gentamicin · Phase 4

Registry ID
NCT00749866
Phase
Phase 4
Status
Completed
Drug / intervention
Gentamicin
Sponsor
University of Edinburgh
Start
2007-05

About this trial

Gentamicin is evaluated in NCT00749866, a Phase 4 idiopathic pulmonary fibrosis study sponsored by University of Edinburgh. Current status: Completed.

View NCT00749866 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT00749866 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.